Chart 26.4.
Diagnostic criteria for DRESS/DIHS proposed by Japanese group
| 1. Maculopapular rash developing >3 weeks after starting therapy with a limited number of drugs |
| 2. Persistent clinical findings after drug withdrawal |
| 3. Fever (>38 °C) |
| 4. Hepatic abnormalities (glutamic pyruvic transaminase >100 U/l)a |
| 5. Leukocyte abnormalities (at least one present) |
| (a) Leukocytosis (>11,000/mm3) |
| (b) Atypical lymphocytosis (>5%) |
| (c) Eosinophilia (>1,500/mm3) |
| 6. HHV-6 reactivationb |
The diagnosis is confirmed by the presence of the seven criteria (typical DIHS) or of the first five criteria (atypical DIHS)
aThis can be replaced by other organ involvement such as renal involvement
bReactivation is detected from the second to third week after symptom onset, through IgG anti-HHV-6 titer elevation